Home  English Website About STADA Sales companies Spain

International sales activities

Spain

In Spain, STADA recorded a sales increase in financial year 2010 in the amount of 12% to EUR 82.8 million (previous year: EUR 73.9 million).

In this Spanish market characterized by an increased growth dynamic, STADA was able – despite significant price reductions – to increase generics sales in financial year 2010 by 14% to EUR 76.9 million (previous year: EUR 67.2 million). In 2010 generics contributed 93% (previous year: 91%) to STADA’s sales in Spain. With a market share of approx. 9.5% (previous year: approx. 8.9%), STADA occupied position 3 in the Spanish generics market in 2010.¹⁾

Sales of branded products decreased by 12% in 2010 to EUR 5.9 million (previous year: EUR 6.7 million). Branded products thus had a 7% share of STADA’s local sales (previous year: 9%).

Operating profitability in the Spanish generics market, was, as expected, positive in 2010, although it was below Group average.

In Spain, sales rose significantly by 35% to EUR 83.1 million in the reporting period
(1-9/2010: EUR 61.8 million).

Sales generated by STADA in the Spanish generics market, characterized by a sustained increased growth dynamic, rose in the first nine months of 2011 by 38% to EUR 78.5 million (1-9/2010: EUR 56.9 million). This was largely due to a very successful product launch on schedule with a patent expiration in the first quarter of 2011. Generics contributed 94% to STADA’s Spanish sales in the reporting period (1-9/2010: 92%).

Sales of branded products decreased by 6% to EUR 4.6 million (1-9/2010: EUR 4.9 million) in the first three quarters of 2011. Branded products thereby had a 6% share of STADA’s local sales (1-9/2010: 8%).

In view of continued strong growth in the generics market, STADA expects additional growth in sales for Spain in financial year 2011. In this local market, operating profitability should be approximately at Group average.

1)	STADA estimate based on IMS Health data at ex-factory prices.

1)	Sales below EUR 0.05 million were rounded to EUR 0.0 million.

www.stada.es